Glacial® Skin by R2 Technologies, Inc.

Glacial® Skin by R2 Technologies, Inc. is a Silicon Valley company that specializes in CryoAesthetic® medical devices aimed at enhancing skin health through precision cooling technology. Founded by experts from Harvard Medical School, R2 Technologies has developed the Glacial® platform, which features the FDA-cleared Glacial® Rx treatment. This innovative treatment uses controlled cooling to reduce inflammation, pain, and swelling, while also addressing skin concerns like acne, melasma, and eczema. The Glacial® platform offers customizable treatment protocols to meet individual patient needs, ensuring effective results. In addition to Glacial® Rx, the platform includes various options such as Glacial® Gloss Rx and Glide Rx, all designed to rejuvenate skin and combat signs of aging. Glacial® Skin primarily serves medical spas, dermatology clinics, and aesthetic practices, with a strong focus on delivering non-invasive treatments that enhance patient satisfaction. The company has achieved significant milestones, including shipping over 100 devices worldwide and delivering more than 15,000 treatment cycles in its first year.

• Employees 48
• Founded 2014
• Annual Revenue $8500000
• Total Funding $55000000